SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Novartis India concludes transfer of its Animal Health Division to Elanco India

01 Jan 2016 Evaluate

Novartis India has completed the transaction for the transfer of its Animal Health Division to Elanco India on December 31, 2015. This is pursuant to the approval received from the Foreign Investment Promotion Board, Government of India and the Competition Commission of India.

The company had earlier entered into transaction for transfer of its Animal Health Division as a going concern by way of a slump sale to Elanco India, or another affiliate of Eli Lilly and Company.

Novartis is a world leader in the research and development of products to protect and improve health and well-being. The company has core businesses in pharmaceuticals, vaccines, consumer health, generics, eye care and animal health.



Novartis Share Price

1112.60 47.15 (4.43%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 222.80
Adani Enterprises 2505.65
Amrapali Industries 18.21
Rashi Peripheral 530.50
PDS 300.95
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×